Theravance Biopharma, Inc. 4

Brett A. Grimaud, SVP, General Counsel and Secretary of Theravance Biopharma, Inc., had 7,952 ordinary shares withheld for taxes following RSU vesting, leaving him with 355,168 shares owned.

On August 20, 2026, Brett A. Grimaud, SVP, General Counsel and Secretary of Theravance Biopharma, Inc., had 7,952 ordinary shares withheld by the company at an implied price of $16.95 per share (approximately $134,852 in value) to satisfy tax obligations arising from the vesting of previously granted restricted stock units; this was a non-open-market, administrative transaction, after which he beneficially owned 355,168 ordinary shares directly.

Filing Facts

CIK

1583107

Ticker

TBPH

Form

4

Source Type

fda

Accession

0001966698-26-000008

Alert Tier

5